The cytokine storm and COVID‐19
B Hu, S Huang, L Yin - Journal of medical virology, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), which began in Wuhan, China, in
December 2019, has caused a large global pandemic and poses a serious threat to public …
December 2019, has caused a large global pandemic and poses a serious threat to public …
[HTML][HTML] Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes
J Van Paassen, JS Vos, EM Hoekstra, KMI Neumann… - Critical Care, 2020 - Springer
Background In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …
use of corticosteroids in COVID-19. In the recent RECOVERY trial, evaluating the effect of …
[HTML][HTML] Cognitive impact of COVID-19: looking beyond the short term
COVID-19 is primarily a respiratory disease but up to two thirds of hospitalised patients show
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …
evidence of central nervous system (CNS) damage, predominantly ischaemic, in some …
Covid-19 and autoimmunity
Though the exact etiology of autoimmune diseases still remains unknown, there are various
factors which are believed to contribute to the emergence of an autoimmune disease in a …
factors which are believed to contribute to the emergence of an autoimmune disease in a …
[HTML][HTML] Pharmaco-immunomodulatory therapy in COVID-19
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
(COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory …
[HTML][HTML] Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad
The pathogenesis of Coronavirus disease 2019 (COVID-19) is gradually being
comprehended. A high number of thrombotic episodes are reported, along with the mortality …
comprehended. A high number of thrombotic episodes are reported, along with the mortality …
[HTML][HTML] COVID-19-associated opportunistic infections: a snapshot on the current reports
Abstract Treatment of the novel Coronavirus Disease 2019 (COVID-19) remains a
complicated challenge, especially among patients with severe disease. In recent studies …
complicated challenge, especially among patients with severe disease. In recent studies …
[HTML][HTML] Myocarditis in COVID-19 patients: current problems
D Mele, F Flamigni, C Rapezzi, R Ferrari - Internal and emergency …, 2021 - Springer
Myocarditis has been reported as a possible clinical presentation or complication in patients
with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this …
with coronavirus disease (COVID)-19 due to SARS-CoV-2. Despite the alarm that this …
[HTML][HTML] Fruitful neutralizing antibody pipeline brings hope to defeat SARS-Cov-2
With the recent spread of severe acute respiratory syndrome coronavirus (SARS-CoV-2) _
infecting> 16 million people worldwide as of 28 July 2020, causing> 650 000 deaths, there …
infecting> 16 million people worldwide as of 28 July 2020, causing> 650 000 deaths, there …
[HTML][HTML] Virus-receptor interactions of glycosylated SARS-CoV-2 spike and human ACE2 receptor
The SARS-CoV-2 betacoronavirus uses its highly glycosylated trimeric Spike protein to bind
to the cell surface receptor angiotensin converting enzyme 2 (ACE2) glycoprotein and …
to the cell surface receptor angiotensin converting enzyme 2 (ACE2) glycoprotein and …